Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens

June 2, 2026 4:30 AM

Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $45.00 price target on Ideaya Biosciences (NASDAQ: IDYA).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found